Core Viewpoint - The company successfully renewed its pharmaceutical production license, extending its validity until December 31, 2030 [2] Group 1 - The subsidiary, Xinxiang Pharmaceutical Co., Ltd., had its original pharmaceutical production license expire on December 31, 2025 [2] - The renewal was issued by the Henan Provincial Drug Administration [2]